September 21, 2009 - Toshiba America Medical Systems Inc. introduced Low-Contrast Imaging (LCI) for Toshiba’s ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 21, 2009 — Minnow Medical recently announced it will be presenting interim clinical data regarding a ...
September 18, 2009 – Boston Scientific today said it completed patient enrollment in the workhorse portion of its ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
September 18, 2009 – Following the recent CE mark certification of the vProtect Luminal Shield, the novel self ...
When vessels are stretched and ripped via angioplasty balloon expansion, the exposed soft muscle tissue can lead ...
A trend that was fueled by cardiologists wanting to gain a larger share of reimbursement fees, while at the same ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Bare metal stents (BMS) were introduced in 1994 as an improvement over balloon angioplasty alone, which had a high ...
September 18, 2009 ¬– Abbott has announced the company's schedule of key news announcements and events during the ...
September 17, 2009 – NMT Medical Inc. said yesterday it will commence data analysis for its landmark STARFlex ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
September 17, 2009 – Boston Scientific Corp. announced its schedule of the company's major events and press ...
September 17, 2009 – Elixir Medical Corp. said today its stent systems using bioabsorbable polymers will be ...
In August Daiichi Sankyo and Eli Lilly and Company launched U.S. sales of Effient (prasugrel), a new antiplatelet ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
Ruptured vulnerable plaque (VP) is blamed for the majority of acute myocardial infarctions and many strokes, but ...
Stenting of lesions at coronary vessel bifurcations is one of the most challenging percutaneous interventions ...
Over the past year several new drug-eluting stents (DES) stents have been released and SYNTAX trial data proved ...